RISPERIDONE, SEROTONERGIC MECHANISMS, AND OBSESSIVE-COMPULSIVE SYMPTOMS IN SCHIZOPHRENIA

被引：0
|
作者：
KOPALA, L
HONER, WG
机构：
来源：
AMERICAN JOURNAL OF PSYCHIATRY | 1994年 / 151卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：1714 / 1715
页数：2
相关论文
共 50 条
  • [1] USE OF RISPERIDONE IN OBSESSIVE-COMPULSIVE SYMPTOMS IN SCHIZOPHRENIA
    KAMLANA, SH
    [J]. JOURNAL OF DRUG DEVELOPMENT AND CLINICAL PRACTICE, 1995, 7 (02): : 127 - 129
  • [2] RISPERIDONE AND OBSESSIVE-COMPULSIVE SYMPTOMS
    REMINGTON, G
    ADAMS, M
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1994, 14 (05) : 358 - 359
  • [3] Obsessive-Compulsive Symptoms in Schizophrenia Induced by Risperidone and Responding to Fluoxetine
    Levy, Emmanuelle
    Margolese, Howard C.
    Sultan, Sarah
    Chouinard, Guy
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (10): : 709 - 710
  • [4] Risperidone and obsessive-compulsive symptoms - Reply
    Remington, G
    Adams, M
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1996, 16 (01) : 85 - 86
  • [5] OBSESSIVE-COMPULSIVE SYMPTOMS IN SCHIZOPHRENIA
    Afkhami, A.
    [J]. EUROPEAN PSYCHIATRY, 2012, 27
  • [6] Obsessive-compulsive symptoms in schizophrenia
    Fabisch, K
    Fabisch, H
    Langs, G
    Wieselmann, G
    Zapotoczky, HG
    [J]. SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 15 - 15
  • [7] Obsessive-compulsive symptoms in schizophrenia
    Afkhami, Azizeh
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2012, 16 : 15 - 15
  • [8] Obsessive-compulsive symptoms in schizophrenia
    Andrade, Chittaranjan
    Garag, Sagar
    Mahadevan, Jayant
    Gorthi, Naga V. S. S.
    [J]. ASIAN JOURNAL OF PSYCHIATRY, 2019, 40 : 23 - 23
  • [9] Obsessive-compulsive symptoms in schizophrenia
    Kayahan, B
    Öztürk, Ö
    Veznedaroglu, B
    [J]. TURK PSIKIYATRI DERGISI, 2005, 16 (03) : 205 - 215
  • [10] Schizophrenia with obsessive-compulsive symptoms
    Pampin Alfonso, A.
    Portela Traba, B.
    Perez Garcia, M.
    Mozos Ansorena, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S494 - S494
12345